Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders.

MLA

Snyder, Gretchen L., et al. “Pharmacologic Profile of ITI-333: A Novel Molecule for Treatment of Substance Use Disorders.” Psychopharmacology, vol. 241, no. 7, July 2024, pp. 1477–90. EBSCOhost, https://doi.org/10.1007/s00213-024-06578-w.

APA

Snyder, G. L., Li, P., Martin, T., Zhang, L., Yao, W., Zheng, H., Maguire, D. R., Gerak, L. R., Vanover, K. E., France, C. P., & Davis, R. (2024). Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders. Psychopharmacology, 241(7), 1477–1490. https://doi.org/10.1007/s00213-024-06578-w

Chicago

Snyder, Gretchen L, Peng Li, Terry Martin, Lei Zhang, Wei Yao, Hailin Zheng, David R Maguire, et al. 2024. “Pharmacologic Profile of ITI-333: A Novel Molecule for Treatment of Substance Use Disorders.” Psychopharmacology 241 (7): 1477–90. doi:10.1007/s00213-024-06578-w.